Descriptive Report of Microorganisms Detected in Cultures of COVID-19 Patients Developing Secondary Infection After Tocilizumab Use
Tocilizumab an anti-inflammatory medication previously approved for the treatment of rheumatoid arthritis, was widely used during the COVID-19 pandemic. Secondary infections following the use of tocilizumab were expected knowing its inhibitory effect on the cascade of inflammation by blocking IL6. P...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shiraz University of Medical Sciences
2024-09-01
|
| Series: | Trends in Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://tips.sums.ac.ir/article_50436_3eebf3edcfb864bcc86fbcfc4a7794bc.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|